Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giron, J. M.
Right arrow Articles by Railhac, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giron, J. M.
Right arrow Articles by Railhac, J. J.

Radiology, Vol 188, 825-827, Copyright © 1993 by Radiological Society of North America

ARTICLES

Inoperable pulmonary aspergilloma: percutaneous CT-guided injection with glycerin and amphotericin B paste in 15 cases

JM Giron, CG Poey, PP Fajadet, GB Balagner, JA Assoun, GR Richardi, JH Haddad, JC Caceres, JP Senac and JJ Railhac
Department of Radiology, Hopitaux de Toulouse, CHU Purpan, France.

Fifteen patients with active inoperable pulmonary aspergilloma underwent percutaneous injection of a special therapeutic paste of glycerin and amphotericin B. This paste was warmed just prior to injection, and filling of the lesional cavity was achieved in one session if it was possible to obtain anaerobic conditions for destruction of the aspergilloma. Injection was performed with computed tomographic guidance with use of an 18-gauge flexible needle and with administration of anti-coughing analgesia. Follow-up was continued for 7 months on average. Filling of the lesion cavities required three sessions on average because of cough or bronchospasm. In 12 cases the aspergilloma regressed within 3 months and results at serology became negative. In three cases, there was no change in the cavity, but hemoptysis did not recur. Results in this series confirm the feasibility and efficacy of this palliative treatment.


This article has been cited by other articles:


Home page
 ChestHome page
J. Camuset, H. Nunes, M.-C. Dombret, A. Bergeron, P. Henno, B. Philippe, G. Dauriat, G. Mangiapan, A. Rabbat, and J. Cadranel
Treatment of Chronic Pulmonary Aspergillosis by Voriconazole in Nonimmunocompromised Patients
Chest, May 1, 2007; 131(5): 1435 - 1441.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
B. Ghaye and R.F. Dondelinger
Imaging guided thoracic interventions
Eur. Respir. J., March 1, 2001; 17(3): 507 - 528.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1993 by the Radiological Society of North America.